H.R. 6478 · 115th Congress

Biosimilars Competition Act of 2018

Stage
In committee
Introduced
2018-07-23
Latest action
2018-07-27 · Referred to the Subcommittee on Health.

Subjects

Administrative law and regulatory procedures
Health
Civil actions and liability
Prescription drugs
Competition and antitrust
Drug safety, medical device, and laboratory regulation
Department of Justice
Contracts and agency
Federal Trade Commission (FTC)